Related Experiment Video
Updated: Jun 4, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
[Optimal lipid treatment: possibilities and current limitations].
1Internistische Praxisgemeinschaft Dres. T. Beckenbauer, S. Maierhof, Hans-Thoma-Strasse 31, Bremen, Germany. klose.bremen@t-online.de
Cardiovascular diseases remain a leading cause of death in Germany. Statins effectively reduce vascular events, but personalized lipid-lowering strategies are crucial for managing residual risk.
Area of Science:
- Cardiology
- Preventive Medicine
- Pharmacology
Context:
- Cardiovascular diseases (CVDs) are the leading cause of death in Germany (42%).
- Healthy lifestyle limitations include poor compliance and variable efficacy.
- Unmet preventive needs persist despite advancements.
Purpose:
- To review the efficacy of statins in reducing major vascular events.
- To discuss the appropriateness of lipid-modulating treatments amidst guideline controversies.
- To explore strategies for ameliorating residual risk in statin-treated patients.
Summary:
- A meta-analysis by the Cholesterol Treatment Trialists' Collaborators shows a 21% average reduction in major vascular events per 1.0 mmol/l LDL cholesterol reduction.
- Current lipid-lowering drugs and future developments are analyzed for clinical practice implications.
- Options beyond LDL-lowering are considered for managing residual cardiovascular risk.
Impact:
- Provides evidence-based insights into statin therapy effectiveness.
- Informs clinical practice regarding lipid-modulating treatment strategies.
- Highlights the importance of personalized approaches to cardiovascular disease prevention.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Lipids: Dietary Sources and Requirements
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Bioavailability Enhancement: Drug Permeability Enhancement
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
